280 related articles for article (PubMed ID: 27778357)
1. Patient selection for the surgical treatment of resectable colorectal liver metastases.
Araujo RL; Riechelmann RP; Fong Y
J Surg Oncol; 2017 Feb; 115(2):213-220. PubMed ID: 27778357
[TBL] [Abstract][Full Text] [Related]
2. Synchronous colorectal liver metastases: the "surgeon as oncologist" perspective.
Shah K; Clary B
Minerva Chir; 2013 Feb; 68(1):49-76. PubMed ID: 23584266
[TBL] [Abstract][Full Text] [Related]
3. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
[TBL] [Abstract][Full Text] [Related]
4. Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection.
Mattar RE; Al-Alem F; Simoneau E; Hassanain M
World J Gastroenterol; 2016 Jan; 22(2):567-81. PubMed ID: 26811608
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary treatment of colorectal liver metastases.
Schiergens TS; von Einem J; Thomas MN; Albertsmeier M; Giessen-Jung C; Dörsch M; Heiliger C; Drefs M; Andrassy J; Modest DP; Stintzing S; Guba M; Angele M; Werner J; Rentsch M
Minerva Med; 2017 Dec; 108(6):527-546. PubMed ID: 28889727
[TBL] [Abstract][Full Text] [Related]
6. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis.
Araujo RL; Gönen M; Herman P
Ann Surg Oncol; 2015 Sep; 22(9):3070-8. PubMed ID: 25586244
[TBL] [Abstract][Full Text] [Related]
8. Extending the frontiers of resectability in advanced colorectal cancer.
Chun YS; Vauthey JN
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S52-8. PubMed ID: 18006265
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
[TBL] [Abstract][Full Text] [Related]
10. [Hepatic metastasis of colorectal cancer--current therapeutic possibilities].
Popescu I; Alexandrescu S
Chirurgia (Bucur); 2010; 105(2):155-69. PubMed ID: 20540227
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel.
Huiskens J; Bolhuis K; Engelbrecht MR; De Jong KP; Kazemier G; Liem MS; Verhoef C; de Wilt JH; Punt CJ; van Gulik TM;
J Am Coll Surg; 2019 Dec; 229(6):523-532.e2. PubMed ID: 31520695
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of colorectal liver metastases - workflow].
Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
Maeda Y; Shinohara T; Nagatsu A; Futakawa N; Hamada T
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S242-8. PubMed ID: 25749931
[TBL] [Abstract][Full Text] [Related]
14. Surgical dilemmas in the management of colorectal liver metastases: The role of timing.
Dimitroulis D; Kouraklis G
World J Gastroenterol; 2016 Jun; 22(21):4963-5. PubMed ID: 27275088
[TBL] [Abstract][Full Text] [Related]
15. A decision analysis model predicts the optimal treatment pathway for patients with colorectal cancer and resectable synchronous liver metastases.
Aloia TA; Fahy BN
Clin Colorectal Cancer; 2008 May; 7(3):197-201. PubMed ID: 18621638
[TBL] [Abstract][Full Text] [Related]
16. [Timing of resection in patients with colorectal carcinoma and synchronous liver metastases].
Hopt UT; Drognitz O; Neeff H
Zentralbl Chir; 2009 Sep; 134(5):425-9. PubMed ID: 19757342
[TBL] [Abstract][Full Text] [Related]
17. Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.
Margonis GA; Kim Y; Sasaki K; Samaha M; Buettner S; Amini N; Pawlik TM
J Surg Oncol; 2016 Sep; 114(3):361-7. PubMed ID: 27264476
[TBL] [Abstract][Full Text] [Related]
18. Resection of Liver Metastases in Colorectal Cancer in the Era of Expanding Systemic Therapy.
Jones RP; Poston GJ
Annu Rev Med; 2017 Jan; 68():183-196. PubMed ID: 27686016
[TBL] [Abstract][Full Text] [Related]
19. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
Ihnát P; Vávra P; Zonča P
World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]